Listen to ASX-listed Imugene Managing Director Leslie Chong talk to Matt Birney on the Bulls N’ Bears Report about Imugene’s “immunotherapy” drug that can laser-target cancerous cells in partnership with an already approved drug, potentially setting up a sublime pairing of products in the vanguard of the fight against cancer.

Listen to ASX-listed Reach Resources CEO Jeremy Bower talk to Matt Birney on the Bulls N’ Bears Report about Reach’s project that is wedged between two companies associated with two titans of WA’s mining exploration scene.  

Listen to ASX-listed White Cliff Minerals Technical Director Ed Mead talk to Matt Birney on the Bulls N’ Bears Report about White Cliff’s buy out of 3 private companies that own 12 rare earths projects – one of which was previously explored by BHP.

Listen to ASX-listed Neometals Managing Director Chris Reed talk to Matt Birney on the Bulls N’ Bears Report about Neometals’ massive titanium project that will pump out over $100m a year for at least the first five years in pre-tax free cash.

Listen to ASX-listed Critical Minerals Group Managing Director Scott Drelincourt talk to Matt Birney on the Bulls N’ Bears Report about Critical Minerals’ massive vanadium resource upgrade that has thrown its Lindfield project into the realms of world class vanadium plays.

Listen to ASX-listed Venture Minerals Managing Director Andrew Radonjic talk to Matt Birney on the Bulls N’ Bears Report about Venture’s brand new rare earths project that came gift-wrapped with two historic drill holes that are begging for follow-up – and they BOTH ended in mineralisation!